Rosalia D'Angelo Selected Research

Retinaldehyde (Retinal)

3/2021	Impairments of Photoreceptor Outer Segments Renewal and Phototransduction Due to a Peripherin Rare Haplotype Variant: Insights from Molecular Modeling.
12/2020	New Omics-Derived Perspectives on Retinal Dystrophies: Could Ion Channels-Encoding or Related Genes Act as Modifier of Pathological Phenotype?
5/2020	Discovery of GLO1 New Related Genes and Pathways by RNA-Seq on A2E-Stressed Retinal Epithelial Cells Could Improve Knowledge on Retinitis Pigmentosa.
4/2020	Transcriptome Analyses of lncRNAs in A2E-Stressed Retinal Epithelial Cells Unveil Advanced Links between Metabolic Impairments Related to Oxidative Stress and Retinitis Pigmentosa.
4/2020	Effects of A2E-Induced Oxidative Stress on Retinal Epithelial Cells: New Insights on Differential Gene Response and Retinal Dystrophies.
1/2019	Role of oxidative stress in Retinitis pigmentosa: new involved pathways by an RNA-Seq analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosalia D'Angelo Research Topics

Disease

6	Trimethylaminuria 11/2021 - 02/2013
5	Retinitis Pigmentosa (Pigmentary Retinopathy) 03/2021 - 11/2018
3	Retinal Degeneration 01/2021 - 11/2018
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Retinal Dystrophies 12/2020 - 04/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2021
1	Atrophy 03/2021
1	Night Blindness (Nyctalopia) 03/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Neuroinflammatory Diseases 12/2020
1	Starvation 04/2020
1	Hyperbilirubinemia 01/2015
1	Gilbert Disease 01/2015
1	Body Odor 02/2013
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Neoplasms (Cancer) 01/2012
1	Multiple Sclerosis 01/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2011

Drug/Important Bio-Agent (IBA)

6	Retinaldehyde (Retinal)IBA 03/2021 - 01/2019
5	trimethylamineIBA 11/2021 - 10/2014
4	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 04/2021 - 02/2013
3	RNA (Ribonucleic Acid)IBA 05/2020 - 01/2019
2	A2-E (N-retinylidene-N-retinylethanolamine)IBA 01/2021 - 11/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 04/2020
2	trimethyloxamine (trimethylamine N-oxide)IBA 10/2014 - 02/2013
1	Proteinase-Activated ReceptorsIBA 01/2022
1	Thrombin FDA Link 01/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 04/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CytokinesIBA 01/2021
1	Ion Channels (Ion Channel)IBA 12/2020
1	Mitochondrial DNA (mtDNA)IBA 11/2020
1	Oxidants (Oxidizing Agents)IBA 05/2020
1	Amino Acids FDA Link 04/2020
1	Melanins (Melanin)IBA 04/2020
1	CarbohydratesIBA 04/2020
1	oxidized low density lipoproteinIBA 11/2018
1	BilirubinIBA 01/2015
1	UGT1A1 enzymeIBA 01/2015
1	OxidesIBA 12/2014
1	EnzymesIBA 10/2014
1	Cyclin D1IBA 01/2012
1	CC ChemokinesIBA 01/2011

Therapy/Procedure

1	Therapeutics 01/2021